Kelly MacDonald
Chief Financial Officer, Dynavax

Kelly MacDonald is Chief Financial Officer at Dynavax, where she leads the finance and accounting functions to execute the company’s strategic and financial objectives in support of its mission to help protect the world against infectious diseases. As a member of Dynavax’s Senior Leadership Team, Ms. MacDonald has played an integral role in driving Dynavax’s strong financial position and has led several important initiatives at the company, including advancing its efforts to foster an inclusive workplace and build a values-driven culture. She joined Dynavax in 2021 from Ironwood Pharmaceuticals where she served in roles of increasing responsibility, including as Chief Accounting Officer and Vice President, Finance, leading the company’s corporate accounting and finance processes, enterprise risk management, treasury and capital allocation strategy. While at Ironwood, Ms. MacDonald also played an integral role in providing financial counsel on the company’s strategic planning, accounting policies, R&D portfolio management, global business development, product launches and commercial execution.

She is a Certified Public Accountant and holds a Bachelor of Science in accounting from Fairfield University and a Master of Business Administration from the Isenberg School of Management at the University of Massachusetts Amherst.